AtriCure
ATRC
230 hedge funds and large institutions have $1.99B invested in AtriCure in 2023 Q3 according to their latest regulatory filings, with 30 funds opening new positions, 93 increasing their positions, 78 reducing their positions, and 20 closing their positions.
50% more first-time investments, than exits
New positions opened: 30 | Existing positions closed: 20
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
19% more repeat investments, than reductions
Existing positions increased: 93 | Existing positions reduced: 78
4% more funds holding
Funds holding: 222 → 230 (+8)
0.55% more ownership
Funds ownership: 95.3% → 95.85% (+0.55%)
10% less capital invested
Capital invested by funds: $2.22B → $1.99B (-$231M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HRCM
Hood River Capital Management
Palm Beach Gardens,
Florida
|
+$41.3M |
| 2 |
NCGI
Next Century Growth Investors
Plymouth,
Minnesota
|
+$15.3M |
| 3 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$14.9M |
| 4 |
TCM
TimesSquare Capital Management
New York
|
+$12.4M |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$4.73M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$42.4M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$10.5M |
| 3 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$10.2M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$8.95M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$8.34M |
ATRC Hedge Fund Activity: Q3 2023 in Review
230 of the 6,310 institutional investors tracked by Wall St. Rank reported a position in AtriCure (ATRC) for Q3 2023, worth a combined $1.99B — down 10% from $2.22B a quarter earlier.
Buyers outnumbered sellers: 30 funds opened new ATRC positions and 20 closed out — a net gain of 10 holders — while 93 added to existing stakes and 78 trimmed.
The largest buyer was Hood River Capital Management, opening a new position worth an estimated $41.3M. The largest seller was Millennium Management, cutting an estimated $42.4M.
- 230 institutional investors held AtriCure (ATRC) as of Q3 2023, up from 222 in Q2 2023.
- Funds reported $1.99B of AtriCure stock for Q3 2023, down 10% quarter-over-quarter.
- 30 funds opened new AtriCure positions in Q3 2023 and 20 closed out, a net change of +10 holders.
- The largest AtriCure buyer in Q3 2023 was Hood River Capital Management, an estimated $41.3M added.
- The largest AtriCure seller in Q3 2023 was Millennium Management, an estimated $42.4M sold.
Based on aggregated 13F filings for Q3 2023.